As of 2025-07-03, the Relative Valuation of NeuroScientific Biopharmaceuticals Ltd (NSB.AX) is 0.11 AUD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 AUD, the upside of NeuroScientific Biopharmaceuticals Ltd based on Relative Valuation is -4.2%.
The range of the Relative Valuation is 0.07 - 0.15 AUD.
| Range | Selected | |
| Trailing P/E multiples | 10.3x - 11.2x | 10.8x |
| Forward P/E multiples | 26.0x - 31.9x | 29.0x |
| Fair Price | 0.07 - 0.15 | 0.11 |
| Upside | -40.3% - 30.2% | -4.2% |
| Date | P/E |
| 2025-06-26 | 5.60 |
| 2025-06-25 | 6.65 |
| 2025-06-24 | 7.02 |
| 2025-06-23 | 7.02 |
| 2025-06-20 | 5.38 |
| 2025-06-18 | 4.48 |
| 2025-06-16 | 4.56 |
| 2025-06-13 | 4.56 |
| 2025-06-12 | 4.93 |
| 2025-06-11 | 5.00 |
| 2025-06-10 | 4.18 |
| 2025-06-06 | 4.11 |
| 2025-06-05 | 3.81 |
| 2025-06-02 | 4.11 |
| 2025-05-30 | 4.33 |
| 2025-05-29 | 4.11 |
| 2025-05-28 | 3.81 |
| 2025-05-27 | 3.96 |
| 2025-05-26 | 4.03 |
| 2025-05-23 | 3.96 |
| 2025-05-22 | 4.03 |
| 2025-05-21 | 4.11 |
| 2025-05-20 | 3.96 |
| 2025-05-19 | 3.58 |
| 2025-05-16 | 3.58 |
| 2025-05-15 | 3.58 |
| 2025-05-14 | 4.00 |
| 2025-05-13 | 3.73 |
| 2025-05-12 | 3.73 |
| 2025-05-08 | 3.96 |
| 2025-05-07 | 3.88 |
| 2025-05-06 | 3.88 |
| 2025-05-05 | 3.66 |
| 2025-05-02 | 3.66 |
| 2025-05-01 | 3.58 |
| 2025-04-30 | 3.88 |
| 2025-04-29 | 3.96 |
| 2025-04-28 | 4.11 |
| 2025-04-24 | 4.11 |
| 2025-04-23 | 3.73 |
| 2025-04-22 | 3.73 |
| 2025-04-17 | 3.36 |
| 2025-04-16 | 3.81 |
| 2025-04-11 | 2.61 |
| 2025-04-10 | 2.61 |
| 2025-04-08 | 2.54 |
| 2025-04-07 | 2.61 |
| 2025-04-04 | 2.69 |
| 2025-04-03 | 2.91 |
| 2025-04-02 | 2.76 |